<DOC>
	<DOCNO>NCT00463866</DOCNO>
	<brief_summary>The purpose study evaluate effect two different maintenance dos Symbicort Maintenance And Reliever Therapy ( SMART ) adult asthmatic patient . A 6 month treatment period</brief_summary>
	<brief_title>Local Phase 4 Pan-European SMART Study</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Patients outpatient clinic &gt; 18 year minimum 6 month document history persistent asthma use inhaled glucocorticosteroids least one month history use rapidacting B2 agonist symptom relief Asthma exacerbation within last 14 day prior study start subject age &gt; 40 year smoke history &gt; 10packyears subject chronic obstructive lung disease significant respiratory disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Asthma</keyword>
</DOC>